CANADABIS CAP (CNADF, $0.04) was a top loser over the last three months, falling -2 to $0.04 per share. A.I.dvisor analyzed 248 stocks in the Pharmaceuticals: Other Industry for the 3-month period ending August 29, 2024, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend.